Overview

E3 Breast Cancer Taxotere Combination

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
To assess the efficacy of ZD6474 in combination with docetaxel in the treatment of ABC using the progression event count methodology
Phase:
Phase 2
Details
Lead Sponsor:
Genzyme, a Sanofi Company
Treatments:
Docetaxel